IDO1 and renal cell adenocarcinoma: Because early (and still extant) chemotherapies for advanced RCC include IFNα [3, 20], we examined the temporal induction of IDO1 by both IFNγ and IFNα in human (ACHN and A498) and mouse RCC (RENCA) cells.